Novel Anti-inflammatory Interleukin-35 as an Emerging Target for Antiatherosclerotic Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|9|1147-1151

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.9, 2015-03, pp. : 1147-1151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MK2: a novel molecular target for anti-inflammatory therapy

By Duraisamy Senthil   Bajpai Malini   Bughani Usha   Dastidar Sunanda G   Ray Abhijit   Chopra Puneet  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 921-936

Informa Healthcare

Access to resources Recommend Favorite

Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5954-5962

Bentham Science Publishers

Access to resources Recommend Favorite

Novel anti-inflammatory therapy for Parkinson's disease

By Gao H.-M.   Liu B.   Zhang W.   Hong J.-S.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 8, 2003-08 ,pp. : 395-401

Elsevier

Access to resources Recommend Favorite

The Emerging Role of the Histamine H4 Receptor in Anti-inflammatory Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-07 ,pp. : 1365-1373

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin Receptor Type 3 as a Potential Target for Anti-Inflammatory Therapy

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-09 ,pp. : 311-315

Bentham Science Publishers

Access to resources Recommend Favorite